A phase II study of vorinostat (MK-0683) in patients with primary myelofibrosis and post-polycythemia vera myelofibrosis. [electronic resource]
Producer: 20140718Description: e5-7 p. digitalISSN:- 1592-8721
No physical items for this record
Publication Type: Clinical Trial, Phase II; Letter
There are no comments on this title.
Log in to your account to post a comment.